(BPMC) Blueprint Medicines complete technical analysis [charts+indicators] | Buy/Sell Blueprint Medicines | (BPMC) share price targets
Complete technical analysis of Blueprint Medicines (BPMC) by charts plus indicators, forecast predictions and share price targets for Blueprint Medicines (BPMC)
Blueprint Medicines trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-25 View latest technical analysis
10 day averaged volume of Blueprint Medicines is 688900
| Date | Daily Closing Price | Open | High | Low | Volume |
| 25 Wed Sep 2024 | 87.00 | 90.20 | 90.80 | 86.92 | 0.703 times |
| 24 Tue Sep 2024 | 90.27 | 89.87 | 90.98 | 89.18 | 0.632 times |
| 23 Mon Sep 2024 | 90.06 | 91.57 | 92.45 | 89.69 | 1.152 times |
| 20 Fri Sep 2024 | 91.68 | 90.86 | 92.94 | 89.70 | 1.708 times |
| 19 Thu Sep 2024 | 90.94 | 91.74 | 93.66 | 90.64 | 0.98 times |
| 18 Wed Sep 2024 | 89.33 | 86.70 | 91.13 | 86.23 | 1.338 times |
| 17 Tue Sep 2024 | 86.51 | 87.21 | 87.42 | 85.64 | 1.036 times |
| 16 Mon Sep 2024 | 86.30 | 89.11 | 89.11 | 85.82 | 0.779 times |
| 13 Fri Sep 2024 | 88.90 | 85.09 | 89.05 | 84.38 | 0.897 times |
| 12 Thu Sep 2024 | 84.10 | 86.58 | 86.65 | 83.91 | 0.682 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 86.3 as stoploss in an intra day buy trade for a target of 89.59. However, stock will show a bearish move below 86.3.
Share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Target | 83.91 |
| Upside Target | 89.05 |
| Upside Target | 95.67 |
| Upside Target | 96.50 |
| Upside Target | 100.67 |
| Upside Target | 106.56 |
| Upside Target | 108.40 |
| Upside Target | 111.02 |
| Upside Target | 111.42 |
| Upside Target | 121.90 |
Intraday share price targets for Blueprint Medicines (BPMC)
| Target Type | Value |
| Downside Intraday Target | 85.13 |
| Downside Intraday Target | 83.26 |
| Upside Intraday Target | 90.66 |
| Upside Intraday Target | 94.32 |
| Upside Intraday Target | 88.79 |
Weekly technical analysis of Blueprint Medicines (BPMC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 25 Wed Sep 2024 | 87.00 | 91.57 | 92.45 | 86.92 | 0.426 times |
| 20 Fri Sep 2024 | 91.68 | 89.11 | 93.66 | 85.64 | 1.237 times |
| 13 Fri Sep 2024 | 88.90 | 86.30 | 89.05 | 83.91 | 1.124 times |
| 06 Fri Sep 2024 | 86.43 | 94.80 | 96.50 | 84.51 | 9.422 times |
| 30 Fri Aug 2024 | 95.54 | 94.52 | 95.67 | 93.14 | 0.184 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Blueprint Medicines (BPMC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 25 Wed Sep 2024 | 87.00 | 94.80 | 96.50 | 83.91 | 0.736 times |
| 30 Fri Aug 2024 | 95.54 | 106.51 | 108.40 | 89.35 | 1.157 times |
| 31 Wed Jul 2024 | 108.30 | 107.68 | 121.90 | 106.56 | 1.132 times |
| 28 Fri Jun 2024 | 107.78 | 106.43 | 111.42 | 100.67 | 0.902 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Blueprint Medicines (BPMC)
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 88.94 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is negative, but sellers have recently become active on the stock. This cannot be called a strong downtrend, specially if selected time duration is small
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a short to mid term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Blueprint Medicines ( (BPMC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Blueprint Medicines stock for short term is SELL. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Blueprint Medicines in short term but the buy signal is initial and weak.
Blueprint Medicines Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Blueprint Medicines in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Blueprint Medicines is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 88.94 and Blueprint Medicines (BPMC) stock is trading below this level. This means that stock is falling with high volumes. VWAP is rising upwards.
People seem to be coming out and selling the Blueprint Medicines (BPMC) stock. Volume based technical analysis of Blueprint Medicines (BPMC) stock is negative.
Blueprint Medicines Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.